메뉴 건너뛰기




Volumn 3, Issue MAY, 2012, Pages

Melanoma vaccines and modulation of the immune system in the clinical setting: Building from new realities

Author keywords

Cancer vaccines; Ctla 4; Immunotherapy; Melanoma

Indexed keywords


EID: 84871390324     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2012.00103     Document Type: Review
Times cited : (6)

References (130)
  • 2
    • 81055127514 scopus 로고    scopus 로고
    • Anti-CTLA4 mon-oclonal antibodies: the past and the future in clinical application
    • Ascierto, P. A., Marincola, F. M., and Ribas, A. (2011). Anti-CTLA4 mon-oclonal antibodies: the past and the future in clinical application. J. Transl. Med. 9, 196.
    • (2011) J. Transl. Med. , vol.9 , pp. 196
    • Ascierto, P.A.1    Marincola, F.M.2    Ribas, A.3
  • 4
    • 33645225168 scopus 로고    scopus 로고
    • The use of oil adjuvants in therapeutic vaccines
    • S2-44-S2-45
    • Aucouturier, J., Ascarateil, S., and Dupuis, L. (2006). The use of oil adjuvants in therapeutic vaccines. Vaccine 24(Suppl. 2), S2-44-S2-45.
    • (2006) Vaccine , vol.24 , Issue.SUPPL. 2
    • Aucouturier, J.1    Ascarateil, S.2    Dupuis, L.3
  • 5
    • 0344299189 scopus 로고    scopus 로고
    • Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous
    • Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W., and Kopf, M. (1999). Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J. Immunol. 163, 1128-1131.
    • (1999) J. Immunol. , vol.163 , pp. 1128-1131
    • Bachmann, M.F.1    Kohler, G.2    Ecabert, B.3    Mak, T.W.4    Kopf, M.5
  • 7
    • 0023785002 scopus 로고
    • Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide
    • Berd, D., and Mastrangelo, M. J. (1988a). Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide. Cancer Invest. 6, 337-349.
    • (1988) Cancer Invest , vol.6 , pp. 337-349
    • Berd, D.1    Mastrangelo, M.J.2
  • 8
    • 0023930413 scopus 로고
    • Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+ 2H4+ suppressor-inducer T-cells
    • Berd, D., and Mastrangelo, M. J. (1988b). Effect of low dose cyclophosphamide on the immune system of cancer patients: depletion of CD4+, 2H4+ suppressor-inducer T-cells. Cancer Res. 48, 1671-1675.
    • (1988) Cancer Res , vol.48 , pp. 1671-1675
    • Berd, D.1    Mastrangelo, M.J.2
  • 9
    • 49649114804 scopus 로고    scopus 로고
    • Phase I safety and pharmacokinetic study of CT-011 a humanized antibody inter-acting with PD-1, in patients with advanced hematologic malignan-cies
    • Berger, R., Rotem-Yehudar, R., Slama, G., Landes, S., Kneller, A., Leiba, M., Koren-Michowitz, M., Shimoni, A., and Nagler, A. (2008). Phase I safety and pharmacokinetic study of CT-011, a humanized antibody inter-acting with PD-1, in patients with advanced hematologic malignan-cies. Clin. Cancer Res. 14,3044-3051.
    • (2008) Clin. Cancer Res. , vol.14 , pp. 3044-3051
    • Berger, R.1    Rotem-Yehudar, R.2    Slama, G.3    Landes, S.4    Kneller, A.5    Leiba, M.6    Koren-Michowitz, M.7    Shimoni, A.8    Nagler, A.9
  • 10
    • 0035217962 scopus 로고    scopus 로고
    • Modes of action of Freund's adju-vants in experimental models of autoimmune diseases
    • Billiau, A., and Matthys, P. (2001). Modes of action of Freund's adju-vants in experimental models of autoimmune diseases. J. Leukoc. Biol. 70, 849-860.
    • (2001) J. Leukoc. Biol. , vol.70 , pp. 849-860
    • Billiau, A.1    Matthys, P.2
  • 12
    • 0027165558 scopus 로고
    • The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
    • Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P., and Boon, T. (1993). The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178, 489-495.
    • (1993) J. Exp. Med. , vol.178 , pp. 489-495
    • Brichard, V.1    Van Pel, A.2    Wolfel, T.3    Wolfel, C.4    De Plaen, E.5    Lethe, B.6    Coulie, P.7    Boon, T.8
  • 15
    • 0035056017 scopus 로고    scopus 로고
    • CTLA-4-mediated inhibi-tion in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy
    • Chambers, C. A., Kuhns, M. S., Egen, J. G., and Allison, J. P. (2001). CTLA-4-mediated inhibi-tion in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu. Rev. Immunol. 19, 565-594.
    • (2001) Annu. Rev. Immunol. , vol.19 , pp. 565-594
    • Chambers, C.A.1    Kuhns, M.S.2    Egen, J.G.3    Allison, J.P.4
  • 18
    • 33747332544 scopus 로고    scopus 로고
    • Malignant melanoma: genetics and therapeutics in the genomic era
    • Chin, L., Garraway, L. A., and Fisher, D. E. (2006). Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev. 20, 2149-2182.
    • (2006) Genes Dev , vol.20 , pp. 2149-2182
    • Chin, L.1    Garraway, L.A.2    Fisher, D.E.3
  • 19
    • 84873076814 scopus 로고    scopus 로고
    • Phytol-derived novel isoprenoid immunostimu-lants
    • doi:10.3389/fimmu.2012.00049
    • Chowdhury, R., and Ghosh, S. (2012). Phytol-derived novel isoprenoid immunostimu-lants. Front. Immunol. 3:49. doi:10.3389/fimmu.2012.00049
    • (2012) Front. Immunol. , vol.3 , pp. 49
    • Chowdhury, R.1    Ghosh, S.2
  • 20
    • 0029925375 scopus 로고    scopus 로고
    • Prognostic value of tumor infiltrating lympho-cytes in the vertical growth phase of primary cutaneous melanoma
    • Clemente, C. G., Mihm, M. C. Jr., Bufalino, R., Zurrida, S., Collini, P., and Cascinelli,N. (1996). Prognostic value of tumor infiltrating lympho-cytes in the vertical growth phase of primary cutaneous melanoma. Cancer 77, 1303-1310.
    • (1996) Cancer , vol.77 , pp. 1303-1310
    • Clemente, C.G.1    Mihm Jr, M.C.2    Bufalino, R.3    Zurrida, S.4    Collini, P.5    Cascinelli, N.6
  • 21
    • 77954855212 scopus 로고    scopus 로고
    • Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination
    • Correll, A., Tuettenberg, A., Becker, C., and Jonuleit, H. (2010). Increased regulatory T-cell frequencies in patients with advanced melanoma correlate with a generally impaired T-cell responsiveness and are restored after dendritic cell-based vaccination. Exp. Dermatol. 19, e213-e221.
    • (2010) Exp. Dermatol. , vol.19
    • Correll, A.1    Tuettenberg, A.2    Becker, C.3    Jonuleit, H.4
  • 24
    • 82455172010 scopus 로고    scopus 로고
    • Therapeutic cancer vaccines: why so few ran-domised phase III studies reflect the initial optimism of phase II studies
    • Dalgleish, A. G. (2011). Therapeutic cancer vaccines: why so few ran-domised phase III studies reflect the initial optimism of phase II studies. Vaccine 29, 8501-8505.
    • (2011) Vaccine , vol.29 , pp. 8501-8505
    • Dalgleish, A.G.1
  • 25
    • 0027538181 scopus 로고
    • Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific,and long-lasting anti-tumor immunity
    • Dranoff, G., Jaffee, E., Lazenby, A., Golumbek, P., Levitsky, H., Brose, K., Jackson, V., Hamada, H., Pardoll, D., and Mulligan, R. C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific,and long-lasting anti-tumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
    • (1993) Proc. Natl. Acad. Sci. U. S. A. , vol.90 , pp. 3539-3543
    • Dranoff, G.1    Jaffee, E.2    Lazenby, A.3    Golumbek, P.4    Levitsky, H.5    Brose, K.6    Jackson, V.7    Hamada, H.8    Pardoll, D.9    Mulligan, R.C.10
  • 26
    • 78650576197 scopus 로고    scopus 로고
    • Use of defined TLR ligands as adjuvants within human vaccines
    • Duthie, M. S., Windish, H. P., Fox, C. B., and Reed, S. G. (2011). Use of defined TLR ligands as adjuvants within human vaccines. Immunol. Rev. 239, 178-196.
    • (2011) Immunol. Rev. , vol.239 , pp. 178-196
    • Duthie, M.S.1    Windish, H.P.2    Fox, C.B.3    Reed, S.G.4
  • 28
    • 84857440345 scopus 로고    scopus 로고
    • Reviewing the somatic genetics of melanoma: from current to future analytical approaches
    • Dutton-Regester, K., and Hayward, N. K. (2012). Reviewing the somatic genetics of melanoma: from current to future analytical approaches. Pig-ment Cell Melanoma Res. 25, 144- 154.
    • (2012) Pig-ment Cell Melanoma Res , vol.25 , pp. 144-154
    • Dutton-Regester, K.1    Hayward, N.K.2
  • 29
    • 0036301503 scopus 로고    scopus 로고
    • CTLA-4:new insights into its biological function and use in tumor immunotherapy
    • Egen,J. G.,Kuhns,M. S.,andAllison,J. P. (2002). CTLA-4:new insights into its biological function and use in tumor immunotherapy. Nat. Immunol. 3, 611-618.
    • (2002) Nat. Immunol. , vol.3 , pp. 611-618
    • Egen, J.G.1    Kuhns, M.S.2    Allison, J.P.3
  • 30
    • 0033565923 scopus 로고    scopus 로고
    • Biodistribu-tion and vaccine efficiency of murine dendritic cells are dependent on the route of administration
    • Eggert, A. A., Schreurs, M. W., Boer-man, O. C., Oyen, W. J., De Boer, A. J., Punt, C. J., Figdor, C. G., and Adema, G. J. (1999). Biodistribu-tion and vaccine efficiency of murine dendritic cells are dependent on the route of administration. Cancer Res. 59, 3340-3345.
    • (1999) Cancer Res , vol.59 , pp. 3340-3345
    • Eggert, A.A.1    Schreurs, M.W.2    Boer-man, O.C.3    Oyen, W.J.4    De Boer, A.J.5    Punt, C.J.6    Figdor, C.G.7    Adema, G.J.8
  • 31
    • 84867552067 scopus 로고    scopus 로고
    • Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial. Can-cer Immunol
    • doi: 10.1007/s00262-012-1242-4
    • Ellebaek, E., Engell-Noerregaard, L., Iversen, T. Z., Froesig, T. M., Munir, S., Hadrup, S. R., Ander-sen, M. H., and Svane, I. M. (2012). Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial. Can-cer Immunol. Immunother. doi: 10.1007/s00262-012-1242-4
    • (2012) Immunother
    • Ellebaek, E.1    Engell-Noerregaard, L.2    Iversen, T.Z.3    Froesig, T.M.4    Munir, S.5    Hadrup, S.R.6    Ander-sen, M.H.7    Svane, I.M.8
  • 33
    • 84965157146 scopus 로고
    • Antigenic proper-ties of methylcholanthrene-induced tumors in mice of the strain of origin
    • Foley, E. J. (1953). Antigenic proper-ties of methylcholanthrene-induced tumors in mice of the strain of origin. Cancer Res. 13, 835-837.
    • (1953) Cancer Res , vol.13 , pp. 835-837
    • Foley, E.J.1
  • 34
    • 75749152896 scopus 로고    scopus 로고
    • Struc-ture and function of programmed death (PD) molecules
    • Folkl, A., and Bienzle, D. (2010). Struc-ture and function of programmed death (PD) molecules.Vet. Immunol. Immunopathol. 134, 33-38.
    • (2010) Vet. Immunol. Immunopathol. , vol.134 , pp. 33-38
    • Folkl, A.1    Bienzle, D.2
  • 35
    • 0037385330 scopus 로고    scopus 로고
    • Foxp3 pro-grams the development and func-tion of CD4+CD25+ regulatory T cells
    • Fontenot, J. D., Gavin, M. A., and Rudensky, A. Y. (2003). Foxp3 pro-grams the development and func-tion of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330-336.
    • (2003) Nat. Immunol. , vol.4 , pp. 330-336
    • Fontenot, J.D.1    Gavin, M.A.2    Rudensky, A.Y.3
  • 36
    • 77953641641 scopus 로고    scopus 로고
    • Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit dis-tinct T cell repertoire
    • Fourcade, J., Sun, Z., Kudela, P., Janjic, B., Kirkwood, J. M., El-Hafnawy, T., and Zarour, H. M. (2010). Human tumor antigen-specific helper and regulatory T cells share common epitope specificity but exhibit dis-tinct T cell repertoire. J. Immunol. 184, 6709-6718.
    • (2010) J. Immunol. , vol.184 , pp. 6709-6718
    • Fourcade, J.1    Sun, Z.2    Kudela, P.3    Janjic, B.4    Kirkwood, J.M.5    El-Hafnawy, T.6    Zarour, H.M.7
  • 37
    • 81955160717 scopus 로고    scopus 로고
    • Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions
    • Fox, C. B., Baldwin, S. L., Duthie, M. S., Reed, S. G., and Vedvick, T. S. (2011). Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions. Vaccine 29, 9563-9572.
    • (2011) Vaccine , vol.29 , pp. 9563-9572
    • Fox, C.B.1    Baldwin, S.L.2    Duthie, M.S.3    Reed, S.G.4    Vedvick, T.S.5
  • 38
    • 77049248972 scopus 로고
    • The mode of action of immunologic adjuvants
    • Freund, J. (1956). The mode of action of immunologic adjuvants. Bibl. Tuberc. 10, 130-148.
    • (1956) Bibl. Tuberc. , vol.10 , pp. 130-148
    • Freund, J.1
  • 39
    • 0042884327 scopus 로고    scopus 로고
    • Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo
    • Garg, S., Oran, A., Wajchman, J., Sasaki, S., Maris, C. H., Kapp, J. A., and Jacob, J. (2003). Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo. Nat. Immunol. 4, 907-912.
    • (2003) Nat. Immunol. , vol.4 , pp. 907-912
    • Garg, S.1    Oran, A.2    Wajchman, J.3    Sasaki, S.4    Maris, C.H.5    Kapp, J.A.6    Jacob, J.7
  • 43
    • 0344585451 scopus 로고    scopus 로고
    • Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma
    • Goldszmid, R. S., Idoyaga, J., Bravo, A. I., Steinman, R., Mordoh, J., and Wainstok, R. (2003). Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma. J. Immunol. 171, 5940-5947.
    • (2003) J. Immunol. , vol.171 , pp. 5940-5947
    • Goldszmid, R.S.1    Idoyaga, J.2    Bravo, A.I.3    Steinman, R.4    Mordoh, J.5    Wainstok, R.6
  • 44
    • 33847220364 scopus 로고    scopus 로고
    • Melanoma biol-ogy and new targeted therapy
    • Gray-Schopfer, V., Wellbrock, C., and Marais, R. (2007). Melanoma biol-ogy and new targeted therapy. Nature 445, 851-857.
    • (2007) Nature , vol.445 , pp. 851-857
    • Gray-Schopfer, V.1    Wellbrock, C.2    Marais, R.3
  • 46
    • 0034614637 scopus 로고    scopus 로고
    • The hallmarks of cancer
    • Hanahan, D., and Weinberg, R. A. (2000). The hallmarks of cancer. Cell 100, 57-70.
    • (2000) Cell , vol.100 , pp. 57-70
    • Hanahan, D.1    Weinberg, R.A.2
  • 53
    • 84857397717 scopus 로고    scopus 로고
    • Interdis-ciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer
    • Huber, M. L., Haynes, L., Parker, C., and Iversen, P. (2012). Interdis-ciplinary critique of sipuleucel-T as immunotherapy in castration-resistant prostate cancer. J. Natl. Cancer Inst. 104, 273-279.
    • (2012) J. Natl. Cancer Inst. , vol.104 , pp. 273-279
    • Huber, M.L.1    Haynes, L.2    Parker, C.3    Iversen, P.4
  • 54
    • 16544383331 scopus 로고    scopus 로고
    • Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity
    • Hugues, S., Fetler, L., Bonifaz, L., Helft, J., Amblard, F., and Amigorena, S. (2004). Distinct T cell dynamics in lymph nodes during the induction of tolerance and immunity. Nat. Immunol. 5, 1235-1242.
    • (2004) Nat. Immunol. , vol.5 , pp. 1235-1242
    • Hugues, S.1    Fetler, L.2    Bonifaz, L.3    Helft, J.4    Amblard, F.5    Amigorena, S.6
  • 55
    • 84855338629 scopus 로고    scopus 로고
    • Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?
    • Jacobs, J. F., Nierkens, S., Figdor, C. G., De Vries, I. J., and Adema, G. J. (2012). Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy? Lancet Oncol. 13, e32-e42.
    • (2012) Lancet Oncol , vol.13
    • Jacobs, J.F.1    Nierkens, S.2    Figdor, C.G.3    De Vries, I.J.4    Adema, G.J.5
  • 57
    • 52549083059 scopus 로고    scopus 로고
    • Selec-tive accumulation of differenti-ated FOXP3(+) CD4(+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood
    • Jandus, C., Bioley, G., Speiser, D. E., and Romero, P. (2008). Selec-tive accumulation of differenti-ated FOXP3(+) CD4(+) T cells in metastatic tumor lesions from melanoma patients compared to peripheral blood. Cancer Immunol. Immunother. 57, 1795-1805.
    • (2008) Cancer Immunol. Immunother. , vol.57 , pp. 1795-1805
    • Jandus, C.1    Bioley, G.2    Speiser, D.E.3    Romero, P.4
  • 58
    • 0037217371 scopus 로고    scopus 로고
    • CD4+CD25+ suppressor lympho-cytes in the circulation of patients immunized against melanoma anti-gens
    • Javia, L. R., and Rosenberg, S. A. (2003). CD4+CD25+ suppressor lympho-cytes in the circulation of patients immunized against melanoma anti-gens. J. Immunother. 26, 85-93.
    • (2003) J. Immunother. , vol.26 , pp. 85-93
    • Javia, L.R.1    Rosenberg, S.A.2
  • 63
    • 0031661414 scopus 로고    scopus 로고
    • QS-21: a water-soluble triterpene glycoside adjuvant
    • Kensil, C. R., and Kammer, R. (1998). QS-21: a water-soluble triterpene glycoside adjuvant. Expert Opin. Investig. Drugs 7, 1475-1482.
    • (1998) Expert Opin. Investig. Drugs , vol.7 , pp. 1475-1482
    • Kensil, C.R.1    Kammer, R.2
  • 65
    • 0035339880 scopus 로고    scopus 로고
    • High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801
    • Kirkwood, J. M., Ibrahim, J. G., Sos-man, J. A., Sondak, V. K., Agarwala, S. S., Ernstoff, M. S., and Rao, U. (2001). High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J. Clin. Oncol. 19, 2370-2380.
    • (2001) J. Clin. Oncol. , vol.19 , pp. 2370-2380
    • Kirkwood, J.M.1    Ibrahim, J.G.2    Sos-man, J.A.3    Sondak, V.K.4    Agarwala, S.S.5    Ernstoff, M.S.6    Rao, U.7
  • 66
    • 79954621235 scopus 로고    scopus 로고
    • Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metasta-tic melanoma
    • Knol, A. C., Nguyen, J. M., Quereux, G., Brocard, A., Khammari, A., and Dreno, B. (2011). Prognostic value of tumor-infiltrating Foxp3+ T-cell subpopulations in metasta-tic melanoma. Exp. Dermatol. 20, 430-434.
    • (2011) Exp. Dermatol. , vol.20 , pp. 430-434
    • Knol, A.C.1    Nguyen, J.M.2    Quereux, G.3    Brocard, A.4    Khammari, A.5    Dreno, B.6
  • 68
    • 77956883758 scopus 로고    scopus 로고
    • FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma
    • Ladanyi, A., Mohos, A., Somlai, B., Liszkay, G., Gilde, K., Fejos, Z., Gaudi, I., and Timar, J. (2010). FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma. Pathol. Oncol. Res. 16, 303-309.
    • (2010) Pathol. Oncol. Res. , vol.16 , pp. 303-309
    • Ladanyi, A.1    Mohos, A.2    Somlai, B.3    Liszkay, G.4    Gilde, K.5    Fejos, Z.6    Gaudi, I.7    Timar, J.8
  • 69
    • 0030595339 scopus 로고    scopus 로고
    • The dorsoven-tral regulatory gene cassette spat-zle/Toll/cactus controls the potent antifungal response in Drosophila adults
    • Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M., and Hoff-mann, J. A. (1996). The dorsoven-tral regulatory gene cassette spat-zle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-983.
    • (1996) Cell , vol.86 , pp. 973-983
    • Lemaitre, B.1    Nicolas, E.2    Michaut, L.3    Reichhart, J.M.4    Hoff-mann, J.A.5
  • 70
    • 84873315606 scopus 로고    scopus 로고
    • Cumulative autoimmu-nity: T cell clones recognizing sev-eral self-epitopes exhibit enhanced pathogenicity
    • doi:10.3389/fimmu.2011.00047
    • Liblau, R., Wekerle, H., and Tisch, R. (2011). Cumulative autoimmu-nity: T cell clones recognizing sev-eral self-epitopes exhibit enhanced pathogenicity. Front. Immunol. 2:47. doi:10.3389/fimmu.2011.00047
    • (2011) Front. Immunol. , vol.2 , pp. 47
    • Liblau, R.1    Wekerle, H.2    Tisch, R.3
  • 72
    • 0031054219 scopus 로고    scopus 로고
    • Tumor cell reactivity medi-ated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibod-ies
    • Livingston, P., Zhang, S., Adluri, S., Yao, T. J., Graeber, L., Ragupathi, G., Helling, F., and Fleisher, M. (1997). Tumor cell reactivity medi-ated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibod-ies. Cancer Immunol. Immunother. 43, 324-330.
    • (1997) Cancer Immunol. Immunother. , vol.43 , pp. 324-330
    • Livingston, P.1    Zhang, S.2    Adluri, S.3    Yao, T.J.4    Graeber, L.5    Ragupathi, G.6    Helling, F.7    Fleisher, M.8
  • 73
    • 84856865635 scopus 로고    scopus 로고
    • Reg-ulatory T cells: banned cells for decades
    • Loser, K., and Beissert, S. (2012). Reg-ulatory T cells: banned cells for decades. J. Invest. Dermatol. 132, 864-871.
    • (2012) J. Invest. Dermatol. , vol.132 , pp. 864-871
    • Loser, K.1    Beissert, S.2
  • 75
    • 0030831210 scopus 로고    scopus 로고
    • A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
    • Medzhitov, R., Preston-Hurlburt, P., and Janeway, C. A. Jr. (1997). A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-397.
    • (1997) Nature , vol.388 , pp. 394-397
    • Medzhitov, R.1    Preston-Hurlburt, P.2    Janeway Jr, C.A.3
  • 76
    • 38449103549 scopus 로고    scopus 로고
    • Utility of tumour-infiltrating CD25+FOXP3+ regula-tory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma
    • Miracco, C., Mourmouras, V., Biagi-oli, M., Rubegni, P., Mannucci, S., Monciatti, I., Cosci, E., Tosi, P., and Luzi, P. (2007). Utility of tumour-infiltrating CD25+FOXP3+ regula-tory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Oncol. Rep. 18, 1115-1122.
    • (2007) Oncol. Rep. , vol.18 , pp. 1115-1122
    • Miracco, C.1    Mourmouras, V.2    Biagi-oli, M.3    Rubegni, P.4    Mannucci, S.5    Monciatti, I.6    Cosci, E.7    Tosi, P.8    Luzi, P.9
  • 77
    • 0014867646 scopus 로고
    • Immuno-logical factors in human sarcomas and melanomas: a rational basis for immunotherapy
    • Morton, D. L., Eilber, F. R., Joseph, W. L., Wood, W. C., Trahan, E., and Ketcham, A. S. (1970). Immuno-logical factors in human sarcomas and melanomas: a rational basis for immunotherapy. Ann. Surg. 172, 740-749.
    • (1970) Ann. Surg. , vol.172 , pp. 740-749
    • Morton, D.L.1    Eilber, F.R.2    Joseph, W.L.3    Wood, W.C.4    Trahan, E.5    Ketcham, A.S.6
  • 78
    • 0014311892 scopus 로고
    • Demonstration of antibodies against human malignant melanoma by immunofluorescence
    • Morton,D. L.,Malmgren,R.A.,Holmes, E. C., and Ketcham, A. S. (1968). Demonstration of antibodies against human malignant melanoma by immunofluorescence. Surgery 64, 233-240.
    • (1968) Surgery , vol.64 , pp. 233-240
    • Morton, D.L.1    Malmgren, R.A.2    Holmes, E.C.3    Ketcham, A.S.4
  • 79
    • 33846519492 scopus 로고    scopus 로고
    • Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity
    • Nair, S., Boczkowski, D., Fassnacht, M., Pisetsky, D., and Gilboa, E. (2007). Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity. Cancer Res. 67, 371-380.
    • (2007) Cancer Res , vol.67 , pp. 371-380
    • Nair, S.1    Boczkowski, D.2    Fassnacht, M.3    Pisetsky, D.4    Gilboa, E.5
  • 81
    • 34547794178 scopus 로고    scopus 로고
    • PD-1 and PD-1 ligands: from discovery to clinical application
    • Okazaki, T., and Honjo, T. (2007). PD-1 and PD-1 ligands: from discovery to clinical application. Int. Immunol. 19, 813-824.
    • (2007) Int. Immunol. , vol.19 , pp. 813-824
    • Okazaki, T.1    Honjo, T.2
  • 82
    • 33748693100 scopus 로고    scopus 로고
    • Dendritic cells loaded with killed allogeneic melanoma cells can induce objec-tive clinical responses and MART-1 specific CD8+ T-cell immunity
    • Palucka, A. K., Ueno, H., Connolly, J., Kerneis-Norvell, F., Blanck, J. P., Johnston, D. A., Fay, J., and Banchereau, J. (2006). Dendritic cells loaded with killed allogeneic melanoma cells can induce objec-tive clinical responses and MART-1 specific CD8+ T-cell immunity. J. Immunother. 29, 545-557.
    • (2006) J. Immunother. , vol.29 , pp. 545-557
    • Palucka, A.K.1    Ueno, H.2    Connolly, J.3    Kerneis-Norvell, F.4    Blanck, J.P.5    Johnston, D.A.6    Fay, J.7    Banchereau, J.8
  • 83
    • 78651072784 scopus 로고    scopus 로고
    • Sin-gle dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance
    • Pedicord, V. A., Montalvo, W., Leiner, I. M., and Allison, J. P. (2011). Sin-gle dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance. Proc. Natl. Acad. Sci. U.S.A. 108, 266-271.
    • (2011) Proc. Natl. Acad. Sci. U. S. A. , vol.108 , pp. 266-271
    • Pedicord, V.A.1    Montalvo, W.2    Leiner, I.M.3    Allison, J.P.4
  • 84
    • 68149155982 scopus 로고    scopus 로고
    • Cham-bers, C. A., Korman, A. J., and Alli-son, J. P
    • Peggs, K. S., Quezada, S. A., Cham-bers, C. A., Korman, A. J., and Alli-son, J. P. (2009). Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies. J. Exp. Med. 206, 1717-1725.
    • (2009) J. Exp. Med. , vol.206 , pp. 1717-1725
    • Peggs, K.S.1    Quezada, S.A.2
  • 86
    • 44949111435 scopus 로고    scopus 로고
    • Par-tial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration
    • Powell, D. J. Jr., Attia, P., Ghetie, V., Schindler, J., Vitetta, E. S., and Rosenberg, S. A. (2008). Par-tial reduction of human FOXP3+ CD4 T cells in vivo after CD25-directed recombinant immunotoxin administration. J. Immunother. 31, 189-198.
    • (2008) J. Immunother. , vol.31 , pp. 189-198
    • Powell Jr, D.J.1    Attia, P.2    Ghetie, V.3    Schindler, J.4    Vitetta, E.S.5    Rosenberg, S.A.6
  • 87
    • 70449193189 scopus 로고
    • Immunity to methylcholanthrene-induced sarcomas
    • Prehn, R. T., and Main, J. M. (1957). Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst. 18, 769-778.
    • (1957) J. Natl. Cancer Inst. , vol.18 , pp. 769-778
    • Prehn, R.T.1    Main, J.M.2
  • 88
    • 33745851479 scopus 로고    scopus 로고
    • CTLA4 blockade and GM-CSF combination immunotherapy alters the intratu-mor balance of effector and regu-latory T cells
    • Quezada, S. A., Peggs, K. S., Curran, M. A., and Allison, J. P. (2006). CTLA4 blockade and GM-CSF combination immunotherapy alters the intratu-mor balance of effector and regu-latory T cells. J. Clin. Invest. 116, 1935-1945.
    • (2006) J. Clin. Invest. , vol.116 , pp. 1935-1945
    • Quezada, S.A.1    Peggs, K.S.2    Curran, M.A.3    Allison, J.P.4
  • 90
    • 70350108862 scopus 로고    scopus 로고
    • Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination
    • Radojcic, V., Bezak, K. B., Skarica, M., Pletneva, M. A., Yoshimura, K., Schulick, R. D., and Luznik, L. (2010). Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination. Cancer Immunol. Immunother. 59, 137-148.
    • (2010) Cancer Immunol. Immunother. , vol.59 , pp. 137-148
    • Radojcic, V.1    Bezak, K.B.2    Skarica, M.3    Pletneva, M.A.4    Yoshimura, K.5    Schulick, R.D.6    Luznik, L.7
  • 91
    • 34247493188 scopus 로고    scopus 로고
    • Nat-urally occurring regulatory T cells: recent insights in health and disease
    • Raimondi, G., Turner, M. S., Thomson, A. W., and Morel, P. A. (2007). Nat-urally occurring regulatory T cells: recent insights in health and disease. Crit. Rev. Immunol. 27, 61-95.
    • (2007) Crit. Rev. Immunol. , vol.27 , pp. 61-95
    • Raimondi, G.1    Turner, M.S.2    Thomson, A.W.3    Morel, P.A.4
  • 96
    • 4644324025 scopus 로고    scopus 로고
    • Cancer immunother-apy: moving beyond current vac-cines
    • Rosenberg, S. A.,Yang, J. C., and Restifo, N. P. (2004). Cancer immunother-apy: moving beyond current vac-cines. Nat. Med. 10, 909-915.
    • (2004) Nat. Med. , vol.10 , pp. 909-915
    • Rosenberg, S.A.1    Yang, J.C.2    Restifo, N.P.3
  • 97
    • 80053508491 scopus 로고    scopus 로고
    • Whole cancer genome sequencing by next-generation methods
    • Ross, J. S., and Cronin, M. (2011). Whole cancer genome sequencing by next-generation methods. Am. J. Clin. Pathol. 136, 527-539.
    • (2011) Am. J. Clin. Pathol. , vol.136 , pp. 527-539
    • Ross, J.S.1    Cronin, M.2
  • 98
    • 33746336533 scopus 로고    scopus 로고
    • The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology
    • Sansom, D. M., and Walker, L. S. (2006). The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology. Immunol. Rev. 212, 131-148.
    • (2006) Immunol. Rev. , vol.212 , pp. 131-148
    • Sansom, D.M.1    Walker, L.S.2
  • 100
    • 24644506094 scopus 로고    scopus 로고
    • CTLA-4 up-regulation of lympho-cyte function-associated antigen 1 adhesion and clustering as an alter-nate basis for coreceptor function
    • Schneider, H., Valk, E., Da Rocha Dias, S., Wei, B., and Rudd, C. E. (2005). CTLA-4 up-regulation of lympho-cyte function-associated antigen 1 adhesion and clustering as an alter-nate basis for coreceptor function. Proc. Natl. Acad. Sci. U.S.A. 102, 12861-12866.
    • (2005) Proc. Natl. Acad. Sci. U. S. A. , vol.102 , pp. 12861-12866
    • Schneider, H.1    Valk, E.2    Da Rocha Dias, S.3    Wei, B.4    Rudd, C.E.5
  • 101
    • 0021917676 scopus 로고
    • Murine epidermal Langerhans cells mature into potent immunostimu-latory dendritic cells in vitro
    • Schuler, G., and Steinman, R. M. (1985). Murine epidermal Langerhans cells mature into potent immunostimu-latory dendritic cells in vitro. J. Exp. Med. 161, 526-546.
    • (1985) J. Exp. Med. , vol.161 , pp. 526-546
    • Schuler, G.1    Steinman, R.M.2
  • 103
    • 0016836061 scopus 로고
    • Intralesional BCG, intravenous immune lym-phocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; a clinical assessment
    • Seigler, H. F., Shingleton, W. W., and Pickrell, K. L. (1975). Intralesional BCG, intravenous immune lym-phocytes, and immunization with neuraminidase-treated tumor cells to manage melanoma; a clinical assessment. Plast. Reconstr. Surg. 55, 294-298.
    • (1975) Plast. Reconstr. Surg. , vol.55 , pp. 294-298
    • Seigler, H.F.1    Shingleton, W.W.2    Pickrell, K.L.3
  • 107
    • 0028800377 scopus 로고
    • Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function
    • Soltysik, S., Wu, J. Y., Recchia, J., Wheeler, D. A., Newman, M. J., Coughlin, R. T., and Kensil, C. R. (1995). Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vac-cine 13, 1403-1410.
    • (1995) Vac-cine , vol.13 , pp. 1403-1410
    • Soltysik, S.1    Wu, J.Y.2    Recchia, J.3    Wheeler, D.A.4    Newman, M.J.5    Coughlin, R.T.6    Kensil, C.R.7
  • 108
    • 33646255944 scopus 로고    scopus 로고
    • Allogeneic and autologous melanoma vaccines: where have we been and where are we going?
    • Sondak, V. K., Sabel, M. S., and Mule, J. J. (2006). Allogeneic and autologous melanoma vaccines: where have we been and where are we going? Clin. Cancer Res. 12, 2337s-2341s.
    • (2006) Clin Cancer Res , vol.12
    • Sondak, V.K.1    Sabel, M.S.2    Mule, J.J.3
  • 109
    • 84857658331 scopus 로고    scopus 로고
    • The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature
    • Sonpavde, G., Di Lorenzo, G., Higano, C. S., Kantoff, P. W., Madan, R., and Shore, N. D. (2012). The role of sipuleucel-T in therapy for castration-resistant prostate cancer: a critical analysis of the literature. Eur. Urol. 61, 639-647.
    • (2012) Eur. Urol. , vol.61 , pp. 639-647
    • Sonpavde, G.1    Di Lorenzo, G.2    Higano, C.S.3    Kantoff, P.W.4    Madan, R.5    Shore, N.D.6
  • 110
    • 0015619335 scopus 로고
    • Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantita-tion, tissue distribution
    • Steinman, R. M., and Cohn, Z. A. (1973). Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantita-tion, tissue distribution. J. Exp. Med. 137, 1142-1162.
    • (1973) J. Exp. Med. , vol.137 , pp. 1142-1162
    • Steinman, R.M.1    Cohn, Z.A.2
  • 111
    • 0000810758 scopus 로고
    • Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice
    • Steinman, R. M., and Witmer, M. D. (1978). Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice. Proc. Natl. Acad. Sci. U.S.A. 75, 5132-5136.
    • (1978) Proc. Natl. Acad. Sci. U. S. A. , vol.75 , pp. 5132-5136
    • Steinman, R.M.1    Witmer, M.D.2
  • 112
    • 34547655923 scopus 로고    scopus 로고
    • A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment
    • Strauss, L., Bergmann, C., Szczepanski, M., Gooding, W., Johnson, J. T., and Whiteside, T. L. (2007). A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin. Cancer Res. 13, 4345-4354.
    • (2007) Clin. Cancer Res. , vol.13 , pp. 4345-4354
    • Strauss, L.1    Bergmann, C.2    Szczepanski, M.3    Gooding, W.4    Johnson, J.T.5    Whiteside, T.L.6
  • 113
    • 0034679560 scopus 로고    scopus 로고
    • Immunologic self-tolerance main-tained by CD25(+)CD4(+) regula-tory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
    • Takahashi, T., Tagami, T., Yamazaki, S., Uede, T., Shimizu, J., Sakaguchi, N., Mak,T. W.,and Sakaguchi,S. (2000). Immunologic self-tolerance main-tained by CD25(+)CD4(+) regula-tory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 192, 303-310.
    • (2000) J. Exp. Med. , vol.192 , pp. 303-310
    • Takahashi, T.1    Tagami, T.2    Yamazaki, S.3    Uede, T.4    Shimizu, J.5    Sakaguchi, N.6    Mak, T.W.7    Sakaguchi, S.8
  • 115
    • 34748849509 scopus 로고    scopus 로고
    • Vaccine therapy for melanoma: current status and future directions
    • Terando, A. M., Faries, M. B., and Mor-ton, D. L. (2007). Vaccine therapy for melanoma: current status and future directions. Vaccine 25(Suppl. 2), B4-B16.
    • (2007) Vaccine , vol.25 , Issue.SUPPL. 2
    • Terando, A.M.1    Faries, M.B.2    Mor-ton, D.L.3
  • 116
    • 39749186213 scopus 로고    scopus 로고
    • Phase III comparison of vitespen, an autolo-gous tumor-derived heat shock pro-tein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 study group
    • Testori, A., Richards, J., Whitman, E., Mann, G. B., Lutzky, J., Camacho, L., Parmiani, G., Tosti, G., Kirkwood, J. M., Hoos, A., Yuh, L., Gupta, R., and Srivastava,P. K. (2008). Phase III comparison of vitespen, an autolo-gous tumor-derived heat shock pro-tein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 study group. J. Clin. Oncol. 26, 955-962.
    • (2008) J. Clin. Oncol. , vol.26 , pp. 955-962
    • Testori, A.1    Richards, J.2    Whitman, E.3    Mann, G.B.4    Lutzky, J.5    Camacho, L.6    Parmiani, G.7    Tosti, G.8    Kirkwood, J.M.9    Hoos, A.10    Yuh, L.11    Gupta, R.12    Srivastava, P.K.13
  • 117
    • 0028867420 scopus 로고
    • Loss of CTLA-4 leads to massive lympho-proliferation and fatal multiorgan tissue destruction,revealing a critical negative regulatory role of CTLA-4
    • Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lympho-proliferation and fatal multiorgan tissue destruction,revealing a critical negative regulatory role of CTLA-4. Immunity 3, 541-547.
    • (1995) Immunity , vol.3 , pp. 541-547
    • Tivol, E.A.1    Borriello, F.2    Schweitzer, A.N.3    Lynch, W.P.4    Bluestone, J.A.5    Sharpe, A.H.6
  • 118
    • 84859158384 scopus 로고    scopus 로고
    • Targeting the PD-1/B7-H1(PD-L1) pathway to acti-vate anti-tumor immunity
    • Topalian, S. L., Drake, C. G., and Par-doll, D. M. (2012). Targeting the PD-1/B7-H1(PD-L1) pathway to acti-vate anti-tumor immunity. Curr. Opin. Immunol. 24, 207-212.
    • (2012) Curr. Opin. Immunol. , vol.24 , pp. 207-212
    • Topalian, S.L.1    Drake, C.G.2    Par-doll, D.M.3
  • 122
    • 34248172345 scopus 로고    scopus 로고
    • Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes
    • von Euw, E. M., Barrio, M. M., Furman, D.,Bianchini,M.,Levy,E. M.,Yee,C., Li, Y., Wainstok, R., and Mordoh, J. (2007). Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes. J. Transl. Med. 5, 19.
    • (2007) J. Transl. Med. , vol.5 , pp. 19
    • von Euw, E.M.1    Barrio, M.M.2    Furman, D.3    Bianchini, M.4    Levy, E.M.5    Yee, C.6    Li, Y.7    Wainstok, R.8    Mordoh, J.9
  • 123
    • 40749136181 scopus 로고    scopus 로고
    • A phase I clinical study of vacci-nation of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells, Analysis of toxicity and immune response to the vaccine and of IL-10-1082 promoter genotype as predic-tor of disease progression
    • von Euw, E. M., Barrio, M. M., Fur-man, D., Levy, E. M., Bianchini, M., Peguillet, I., Lantz, O., Vellice, A., Kohan, A., Chacon, M., Yee, C., Wainstok, R., and Mordoh, J. (2008). A phase I clinical study of vacci-nation of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predic-tor of disease progression. J. Transl. Med. 6, 6.
    • (2008) J. Transl. Med. , vol.6 , pp. 6
    • von Euw, E.M.1    Barrio, M.M.2    Fur-man, D.3    Levy, E.M.4    Bianchini, M.5    Peguillet, I.6    Lantz, O.7    Vellice, A.8    Kohan, A.9    Chacon, M.10    Yee, C.11    Wainstok, R.12    Mordoh, J.13
  • 124
    • 1642497640 scopus 로고    scopus 로고
    • Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy
    • Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., and Wang, R. F. (2004). Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy. Immunity 20, 107-118.
    • (2004) Immunity , vol.20 , pp. 107-118
    • Wang, H.Y.1    Lee, D.A.2    Peng, G.3    Guo, Z.4    Li, Y.5    Kiniwa, Y.6    Shevach, E.M.7    Wang, R.F.8
  • 125
    • 0030472678 scopus 로고    scopus 로고
    • Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
    • Wang, R. F., Appella, E., Kawakami, Y., Kang, X., and Rosenberg, S. A. (1996). Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes. J. Exp. Med. 184, 2207-2216.
    • (1996) J. Exp. Med. , vol.184 , pp. 2207-2216
    • Wang, R.F.1    Appella, E.2    Kawakami, Y.3    Kang, X.4    Rosenberg, S.A.5
  • 127
    • 84862135169 scopus 로고    scopus 로고
    • What are regula-tory T cells (Treg) regulating in can-cer and why?
    • doi: 10.1016/j.semcancer.2012.03.004
    • Whiteside,T. L. (2012).What are regula-tory T cells (Treg) regulating in can-cer and why? Semin. Cancer Biol. doi: 10.1016/j.semcancer.2012.03.004
    • (2012) Semin Cancer Biol
    • Whiteside, T.L.1
  • 130
    • 33645286546 scopus 로고    scopus 로고
    • Regulatory T cells, tumour immunity and immunotherapy
    • Zou, W. (2006). Regulatory T cells, tumour immunity and immunotherapy. Nat. Rev. Immunol. 6, 295-307.
    • (2006) Nat. Rev. Immunol. , vol.6 , pp. 295-307
    • Zou, W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.